These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28264642)

  • 21. Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans.
    Robin M; Schlageter MH; Chomienne C; Padua RA
    Cancer Immunol Immunother; 2005 Oct; 54(10):933-43. PubMed ID: 15889256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in immunotherapy for acute myeloid leukemia.
    Przespolewski A; Szeles A; Wang ES
    Future Oncol; 2018 Apr; 14(10):963-978. PubMed ID: 29542352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy in the treatment of acute leukaemia.
    Whittaker JA
    Br J Haematol; 1980 Jun; 45(2):187-93. PubMed ID: 6934004
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immune stimulation as oncologic therapy, especially in acute leukemia].
    Olsson L
    Ugeskr Laeger; 1977 Apr; 139(15):876-9. PubMed ID: 265645
    [No Abstract]   [Full Text] [Related]  

  • 25. Novel targets and technologies for CAR-T cells in multiple myeloma and acute myeloid leukemia.
    Prommersberger S; Jetani H; Danhof S; Monjezi R; Nerreter T; Beckmann J; Einsele H; Hudecek M
    Curr Res Transl Med; 2018 May; 66(2):37-38. PubMed ID: 29655962
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunotherapy of acute myeloid leukaemia: development of a whole cell vaccine.
    Cheuk AT; Guinn BA
    Front Biosci; 2008 Jan; 13():2022-9. PubMed ID: 17981688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy for acute myelogenous leukemia using irradiated and unirradiated leukemia cells.
    Powles R
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1558-62. PubMed ID: 4608692
    [No Abstract]   [Full Text] [Related]  

  • 28. Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia-associated antigens and current clinical protocols targeting these antigens.
    Greiner J; Döhner H; Schmitt M
    Haematologica; 2006 Dec; 91(12):1653-61. PubMed ID: 17145602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marrow transplantation for acute myeloid leukemia.
    Clift RA; Buckner CD
    Cancer Invest; 1998; 16(1):53-61. PubMed ID: 9474253
    [No Abstract]   [Full Text] [Related]  

  • 30. Advances in immunotherapy for pediatric acute myeloid leukemia.
    Bonifant CL; Velasquez MP; Gottschalk S
    Expert Opin Biol Ther; 2018 Jan; 18(1):51-63. PubMed ID: 28945115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Active specific immunization with allogeneic leukemia associated antigens or irradiated allogeneic leukemia cells in acute leukemia.
    Ezaki K; Hersh EM; Keating M; Dyre S; Hollinshead A; McCredie KB; Mavlight GM; Gutterman JU
    Cancer; 1978 Jan; 41(1):70-83. PubMed ID: 75055
    [No Abstract]   [Full Text] [Related]  

  • 32. Active specific immunotherapy for acute myelogenous leukaemia.
    Powles R
    Johns Hopkins Med J Suppl; 1974; 3():333-40. PubMed ID: 4609353
    [No Abstract]   [Full Text] [Related]  

  • 33. Antigen-directed therapies: an effective tool in acute myeloid leukemia?
    Walter RB
    Immunotherapy; 2016 Oct; 8(10):1153-6. PubMed ID: 27605064
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapeutic approach to acute myeloid leukemia].
    Ferrant A
    Bull Mem Acad R Med Belg; 1998; 153(2):161-8; discussion 168-9. PubMed ID: 9760758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alloantisera to human leukemic blast cells: detection of leukemia-associated antigens (LAA).
    Baker MA; Falk JA; Taub RN
    Prog Clin Biol Res; 1977; 16():103-7. PubMed ID: 71741
    [No Abstract]   [Full Text] [Related]  

  • 36. Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.
    Atanackovic D; Luetkens T; Kloth B; Fuchs G; Cao Y; Hildebrandt Y; Meyer S; Bartels K; Reinhard H; Lajmi N; Hegewisch-Becker S; Schilling G; Platzbecker U; Kobbe G; Schroeder T; Bokemeyer C; Kröger N
    Am J Hematol; 2011 Nov; 86(11):918-22. PubMed ID: 21898529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the acute myeloid leukemic stem cell compartment by enhancing tumor cell-based vaccines.
    Ruben JM; Visser LL; Bontkes HJ; Westers TM; Ossenkoppele GJ; de Gruijl TD; van de Loosdrecht AA
    Immunotherapy; 2013 Aug; 5(8):859-68. PubMed ID: 23902555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Active immunotherapy in leukemia with neuraminidase-modified leukemic cells.
    Bekesi JG; Holland JF
    Recent Results Cancer Res; 1977; (62):78-89. PubMed ID: 203005
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute myeloid leukemia and novel biological treatments: monoclonal antibodies and cell-based gene-modified immune effectors.
    Tettamanti S; Magnani CF; Biondi A; Biagi E
    Immunol Lett; 2013; 155(1-2):43-6. PubMed ID: 24076117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The progress and current status of immunotherapy in acute myeloid leukemia.
    Yang D; Zhang X; Zhang X; Xu Y
    Ann Hematol; 2017 Dec; 96(12):1965-1982. PubMed ID: 29080982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.